Showing 1241-1250 of 2192 results for "".
Neurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPHEditor's Message
https://practicalneurology.com/columns/practice-management/editors-message/30856/- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0608Dementia-pdf/31012/Current Alzheimer’s disease (AD) research predominantly targets the reduction and elimination of beta-amyloid 42 and phosphorylated Tau proteins, aiming to develop disease-modifying treatments. These pathological markers are critical in the onset and progression of AD, and intervening in their pathw
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31022/Advancements in Transient Ischemic Attack Management: Insights from the FASTER StudyRecent research published in Practical Neurology highlights critical findings from the Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) study. This pilot clinical trial inv
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31105/Zonisamide as an Adjunctive Therapy in Parkinson’s Disease: Insights and ImplicationsZonisamide, traditionally an anticonvulsant, has emerged as a promising adjunctive treatment for Parkinson’s disease (PD). A pivotal study published in January 2007 in *Neurology* demonstrated that zonisamide, admin
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0107PainMngmnt-pdf/31230/Comprehensive Strategies for Long-Term Management of Chronic Low Back PainChronic low back pain (CLBP) presents significant challenges in long-term management, particularly when patients exhibit inadequate responses to pharmacologic treatments. Dr. Charles Argoff emphasizes the importance of tailore
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31256/Practical Neurology November 2006: Key Developments in Neurological MedicineRecent findings in neurology highlight significant advancements and challenges in patient care and treatment strategies. A pivotal study on the gene GCH1 revealed its critical role in pain modulation. Researchers demonstrate
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31277/Optimizing Antihypertensive Therapy for Stroke Prevention: Insights for NeurologistsAntihypertensive therapy stands as the cornerstone of stroke prevention, significantly reducing stroke recurrence more effectively than many other medical interventions, including antiplatelet and cholesterol-lowerin
- Medicare Audits: The “Fight is On”https://practicalneurology.com/columns/practice-management/medicare-audits-the-fight-is-on/31453/Navigating Evolving Medicare Audits: Strategies for Neurology PractitionersThe realm of Medicare auditing is becoming increasingly intricate, urging neurologists and other healthcare professionals to reassess their billing practices and compliance measures. Recent regulatory updates have transformed
Botox for Chronic Migraine: Tips and Tricks
https://practicalneurology.com/diseases-diagnoses/headache-pain/botox-for-chronic-migraine-tips-and-tricks/30277/Ten Questions for Andrew M. Blumenfeld, MD